- Home
- EVGN vs MTNB Comparison
EVGN vs MTNB Comparison
Compare EVGN & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- MTNB
- Stock Information
- Founded
- EVGN 1999
- MTNB 2013
- Country
- EVGN Israel
- MTNB United States
- Employees
- EVGN N/A
- MTNB N/A
- Industry
- EVGN Agricultural Chemicals
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- EVGN Industrials
- MTNB Health Care
- Exchange
- EVGN Nasdaq
- MTNB Nasdaq
- Market Cap
- EVGN 10.9M
- MTNB 10.8M
- IPO Year
- EVGN N/A
- MTNB N/A
- Fundamental
- Price
- EVGN $1.31
- MTNB $1.45
- Analyst Decision
- EVGN Strong Buy
- MTNB Hold
- Analyst Count
- EVGN 1
- MTNB 1
- Target Price
- EVGN $3.50
- MTNB N/A
- AVG Volume (30 Days)
- EVGN 150.4K
- MTNB 37.7K
- Earning Date
- EVGN 11-20-2025
- MTNB 11-12-2025
- Dividend Yield
- EVGN N/A
- MTNB N/A
- EPS Growth
- EVGN N/A
- MTNB N/A
- EPS
- EVGN N/A
- MTNB N/A
- Revenue
- EVGN $9,444,000.00
- MTNB N/A
- Revenue This Year
- EVGN N/A
- MTNB N/A
- Revenue Next Year
- EVGN $12.35
- MTNB N/A
- P/E Ratio
- EVGN N/A
- MTNB N/A
- Revenue Growth
- EVGN 42.25
- MTNB N/A
- 52 Week Low
- EVGN $0.95
- MTNB $0.47
- 52 Week High
- EVGN $2.87
- MTNB $3.35
- Technical
- Relative Strength Index (RSI)
- EVGN 54.40
- MTNB 34.65
- Support Level
- EVGN $1.21
- MTNB $1.82
- Resistance Level
- EVGN $1.32
- MTNB $1.67
- Average True Range (ATR)
- EVGN 0.08
- MTNB 0.13
- MACD
- EVGN -0.00
- MTNB -0.04
- Stochastic Oscillator
- EVGN 36.03
- MTNB 3.26
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.